#Autolomous
LightNews LightNews
thepharmanavigator.bsky.social
Biotech SaaS company, Autolomous, and UK-based biotech, Cellular Origins, have announced an integration of their respective platforms to combine automation with cell therapy manufacturing.

Find out more👇
www.thepharmanavigator.com/news/autolom...
Autolomous and Cellular Origins Target Cell Therapy Scale-Up Challenges with Partnership — The Pharma Navigator - Navigating The Key News Stories In Pharma
The integration of Autolomous’ autoloMATE system and Cellular Origins’ Constellation platforms aims to standardize and digitize cell therapy manufacturing within existing bioprocess infrastructure.
www.thepharmanavigator.com
July 24, 2026 at 1:09 PM
catapultnetwork.bsky.social
@cgtcatapult.bsky.social and Autolomous have revolutionised #AdvancedTherapy manufacturing, replacing paper-based systems with automated, data-driven workflows.

The result: 65% faster reviews, near-zero data errors, and zero waste! ♻️

🔗 https://loom.ly/eIzyvTA
November 26, 2025 at 10:01 AM
4040rec.bsky.social
#CGTmanufacturing #CellularOrigins #Constellation #cellandgenetherapymanufacturing #cellandgenetherapies #CGT #CGTproduction #CellandGeneTherapyCatapult #CGTCatapult #ResolutionTherapeutics #biomanufacturing #robotictechnologies #bioreactortechnology #Autolomous
pharmaphorum.com/news/uk-proj...
UK project addresses capacity issue in CGT manufacturing
A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.
pharmaphorum.com
July 17, 2025 at 9:53 AM
thepharmanavigator.bsky.social
In the latest episode of From Stem to Stern, The Pharma Navigator sits down with Stuart Lowe (TTP plc) and Gerhard Bauer (Autolomous) to explore how tailored therapies are reshaping the treatment landscape.

Watch the interview below👇
www.thepharmanavigator.com/news/transfo...
Transforming the Treatment Landscape with Tailored Therapies — The Pharma Navigator - Navigating The Key News Stories In Pharma
Patient outcomes are transforming, thanks to innovative, curative, tailored therapies; however, industry needs to address a few pressing issues to ensure the huge promise of these drugs can be…
www.thepharmanavigator.com
March 11, 2026 at 2:48 PM
cgtcatapult.bsky.social
Autolomous Ltd and the Cell and Gene Therapy Catapult have demonstrated how digital platforms can transform #cell & #gene therapy manufacturing.

Read the whitepaper to learn how digital technologies can drive scalability, efficiency & cost-effectiveness in #ATMP manufacturing: ow.ly/KGIt50X6U31
October 6, 2025 at 8:30 AM
drtimos.bsky.social
Thoughts on this? >> Trenchant & Autolomous Partner to Accelerate Cell
& Gene Therapy Manufacturing - Contract Pharma: Trenchant & Autolomous Partner to Accelerate Cell… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #competitivemarketing #healthcare #pharma
Trenchant & Autolomous Partner to Accelerate Cell & Gene Therapy Manufacturing - Contract Pharma
Trenchant & Autolomous Partner to Accelerate Cell & Gene Therapy Manufacturing  Contract Pharma
dlvr.it
January 20, 2025 at 7:30 PM